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A 9.8-kb DNA region from the oleandomycin gene cluster in Streptomyces antibioticus was cloned. Sequence
analysis revealed the presence of 8 open reading frames encoding different enzyme activities involved in the
biosynthesis of one of the two 2,6-deoxysugars attached to the oleandomycin aglycone: L-oleandrose (the oleW,
oleV, oleL, and oleU genes) and D-desosamine (the oleNI and oleT genes), or of both (the oleS and oleE genes).
A Streptomyces albus strain harboring the oleG2 glycosyltransferase gene integrated into the chromosome was
constructed. This strain was transformed with two different plasmid constructs (pOLV and pOLE) containing
a set of genes proposed to be required for the biosynthesis of dTDP-L-olivose and dTDP-L-oleandrose,
respectively. Incubation of these recombinant strains with the erythromycin aglycon (erythronolide B) gave rise
to two new glycosylated compounds, identified as L-3-O-olivosyl- and L-3-O-oleandrosyl-erythronolide B, indi-
cating that pOLV and pOLE encode all enzyme activities required for the biosynthesis of these two 2,6-
dideoxysugars. A pathway is proposed for the biosynthesis of these two deoxysugars in S. antibioticus.
The macrolide group of antibiotics comprises a series of
compounds mainly active against gram-positive bacteria with
clinical application in the treatment of bacterial infections.
Oleandomycin (Fig. 1A) is a 14-unit macrolide synthesized by
Streptomyces antibioticus. Structurally it contains a macrolac-
tone ring (oleandolide) which is synthesized by the assembly of
one starter acetyl coenzyme A (CoA) and six extender meth-
ylmalonyl CoA units. To this aglycone, two 6-deoxysugars (L-
oleandrose and D-desosamine) are later attached and, proba-
bly as late steps in biosynthesis, C-8 hydroxylation and epoxide
formation occur after the transfer of the two sugar residues
onto the macrolactone. Previous studies have characterized
genes involved in the biosynthesis of the polyketide moiety of
oleandomycin, genes involved in oleandomycin resistance and
secretion, and genes involved in sugar biosynthesis and glyco-
sylation. A large gene encoding the third subunit of the ole-
andomycin type I polyketide synthase (PKS) has been cloned
and sequenced, showing an unusual coding sequence for Strep-
tomyces genes (54). This gene product would catalyze the last
two condensation cycles in the biosynthesis of the macrolac-
tone. Two oleandomycin resistance genes (oleB and oleC) have
been also cloned and characterized, both encoding ATP-bind-
ing cassette (ABC) transporters (34, 44). It has been demon-
strated that oleB, an ABC transporter located within the ole-
andomycin gene cluster, can secrete an inactive glycosylated
oleandomycin intermediate (34). Two glycosyltransferase
genes (oleI and oleD) and a b-glycosidase (oleR) gene have
been identified (20, 43) and shown to participate in modifying
oleandomycin intermediates to produce a final inactive intra-
cellular glycosylated derivative (42, 58) that is reactivated after
secretion (41). In addition, a gene (oleP) encoding a cyto-
chrome P450 monooxygenase has also been described; it may
be responsible for the introduction of the epoxide group char-
acteristic of oleandomycin as one of the latest steps in olean-
domycin biosynthesis (45). Recently, five additional genes in-
volved in sugar biosynthesis (oleP1, oleM1, and oleY) and sugar
transfer (oleG1 and oleG2) have been reported (35). A proof
for the involvement of this chromosomal region in oleandom-
ycin biosynthesis was obtained by insertional inactivation of the
oleG1 gene, resulting in a nonproducing mutant (35).
Here we report the identification of eight additional genes
involved in the biosynthesis of D-desosamine and L-oleandrose.
A pathway is proposed for the biosynthesis of these two 6-de-
oxysugars by S. antibioticus, and roles are suggested for the
different sugar-biosynthetic genes, including those reported
here as well as others reported previously (35, 43). We also
report the construction of two plasmids capable of promoting
the biosynthesis of dTDP-L-olivose and dTDP-L-oleandrose,
and evidence is presented for the transfer of these two dTDP-
activated sugars to the erythromycin aglycone (erythronolide
B) by the oleandrosyl glycosyltransferase (oleG2).
MATERIALS AND METHODS
Microorganisms, culture conditions, and vectors. S. antibioticus ATCC 11891,
an oleandomycin producer, was used as a donor of chromosomal DNA. Growth
in liquid medium was carried out at 30°C in Trypticase soy broth (TSB; Oxoid).
Streptomyces albus J1074 (ilv-1 sal-2 R2 M2) (6) was used as a host for biotrans-
formation experiments. Escherichia coli XL1-Blue (5) was used as a host for
subcloning. Plasmids are listed in Table 1. pIJ2925 (23) and pUC18 (63) were
used as vectors for subcloning experiments and DNA sequencing. pKCE is an
integrative plasmid vector derived from pKC796 (24) in which the erythromycin
resistance gene (ermE) was cloned as a 1.7-kb BglII fragment into the BamHI site
of this vector (E. Ferna´ndez, unpublished data). pIAGO is a multicopy replica-
tive bifunctional (Streptomyces-E. coli) plasmid derived from pWHM3 (57) that
contains the promoter of the erythromycin resistance gene (ermE) from Saccha-
ropolyspora erythraea as a 0.28-kb KpnI-BamHI fragment and that can be selected
by resistance to thiostrepton in Streptomyces and to ampicillin in E. coli. pIAGO
was used for gene expression in Streptomyces. pEM4 was used for subcloning and
gene expression in Streptomyces (43). When antibiotic selection of transformants
was needed, 25 mg of thiostrepton/ml, 25 mg of apramycin/ml, or 200 mg of
erythromycin/ml was used.
DNA manipulation and sequencing. Plasmid DNA preparations, restriction
endonuclease digestions, alkaline phosphatase treatments, ligations, and other
DNA manipulations were carried out according to standard procedures for E.
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coli (47) and for Streptomyces (21). Southern hybridization was performed ac-
cording to standard procedures (21). Sequencing was performed by using the
dideoxynucleotide chain termination method (48) and the Cy5 AutoCycle Se-
quencing Kit (Pharmacia Biotech). Both DNA strands were sequenced with
primers supplied in the kits or with internal oligoprimers (17-mer) using an
ALF-express automatic DNA sequencer (Pharmacia). Computer-assisted data-
base searching and sequence analyses were carried out using the University of
Wisconsin Genetics Computer Group program package (9) and the BLASTP
program (1).
Construction of an S. albus strain expressing oleG2. pUC2G is a pUC18
construct containing a 5.8-kb BglII fragment subcloned into the BamHI site of
the vector. The insert in pUC2G contains the 39 end of the third subunit of the
oleandomycin PKS gene and the entire oleP1, oleG1, and oleG2 group of genes.
From this construct, a 1.45-kb BamHI-EcoRI fragment carrying the oleG2 gene
(the BamHI site is shown in Fig. 1B and the EcoRI site comes from the pUC
polylinker) was subcloned into the same sites of pEM4. In this construct
(pNAG2-1) the oleG2 gene is now under the transcriptional control of the
erythromycin resistance gene promoter (ermE*p). To place appropriate restric-
tion sites at both ends of ermE*p and oleG2, the fragment was rescued from
pNAG2-1 as a 1.7-kb HindIII-EcoRI fragment and subcloned into the same sites
of pIJ2925, generating pNAG2-2. Then a 1.7-kb BglII fragment was subcloned
into the BglII site of the integrative vector pKCE, generating pNAG2-3. This
construct contains two divergent ermEp’s, one controlling transcription of oleG2
and the other controlling that of ermE. pNAG2-3 was digested with XhoI, blunt
ended, and religated in order to inactivate the apramycin resistance gene. This
selectable marker was eliminated from this construct in order to have the pos-
sibility in the future of introducing into the strain harboring this construct other
plasmids containing the apramycin cassette as an antibiotic marker. The final
construct was then used to transform S. albus protoplasts, and transformants
were selected by their resistance to erythromycin (200 mg/ml). Then erythromy-
cin-resistant colonies were assayed for their sensitivity to 25 mg of apramycin/ml
by replica plating. One of these colonies (strain NAG2) was selected as a host for
further studies.
Construction of plasmids synthesizing dTDP-L-olivose and dTDP-L-olean-
drose. Two plasmids containing sugar-biosynthetic genes were constructed as
follows.
(i) dTDP-L-olivose-synthesizing plasmid. A 7.6-kb SstI fragment (shown in
Fig. 1B) from cosAB61 (containing the oleW, oleV, oleL, oleS, oleE, and oleU
genes and the 59 end of oleNI) was subcloned into the SstI site of pIAGO
upstream of ermEp, generating pOLV. This construct contains all the putative
oleandrose-biosynthetic genes except the oleY gene, which is located at the other
end of the cluster downstream of the polyketide synthase genes (see Fig. 1B).
Transcription of these genes in this construct is dependent upon their own
promoters.
(ii) dTDP-L-oleandrose-synthesizing plasmid. The oleY gene was amplified by
PCR using the following oligoprimers: 59 AGAGAAGCTTGCTAGCCCGGA
CCACGCGAAGGACCTTTCACATG 39 for the 59 end of the gene and 59
AGTCTAGATTAATTAACTAGTTGTCGTTCCAGAACGGCTCCCGGG 39
for the 39 end of the gene (HindIII and NheI sites [underlined] were included in
the first oligoprimer, and PacI and XbaI sites [underlined] were included in the
second, to facilitate subcloning). PCR conditions were as follows. One hundred
nanograms of template DNA was mixed with 30 pmol of each primer and 2 U of
Vent DNA polymerase (New England Biolabs) in a total reaction volume of 50
ml containing 2 mM each deoxynucleoside triphosphate, 10 mM KCl, 10 mM
(NH4)2SO4, 20 mM Tris-HCl (pH 8.8), 2 mM MgSO4, 0.1% Triton X-100, and
FIG. 1. (A) Structure of oleandomycin. (B) Schematic representation of the oleandomycin gene cluster. Solid bars, DNA regions hybridizing against the strDEM
genes from the streptomycin pathway; open bars, locations of the 7.6-kb SstI fragment and the PCR-amplified oleY gene. B, BamHI; S, SstI; PKS, PKS genes.
TABLE 1. Plasmid constructs used in this study
Plasmid Characteristic(s) Source orreference
pIJ2925 pUC derivative 23





pIAGO pWHM3 containing a 0.28-kb KpnI-
BamHI fragment including the
erythromycin resistance promoter
This study
pEM4 pWHM4 containing the
erythromycin resistance promoter
43
pUC2G pUC18 with a 5.8-kb BglII fragment
from cosAB35 containing the 39
end of the third subunit of the
oleandomycin PKS gene, oleP1,
oleG1, and oleG2
This study
pOLV pIAGO containing a 7.6-kb SstI
fragment including the oleW, oleV,
oleL, oleS, oleE, and oleU genes
and the 59 end of oleNI
This study
pOLE pOLV containing a 1.1-kb PCR
fragment including the oleY gene
This study
pNAG2-1 pEM4 with a 1.4-kb BamHI-EcoRI
fragment from pUC2G
This study
pNAG2-2 pIJ2925 with a 1.7-kb HindIII-EcoRI
fragment from pNAG2-1
This study
pNAG2-3 pKCE with a 1.7-kb BglII fragment
from pNAG2-2
This study













10% dimethyl sulfoxide (Merck). This reaction mixture was overlaid with 50 ml
of mineral oil (Sigma), and the polymerization reaction was performed in a
thermocycler (MiniCycler; MJ Research) under the following conditions: an
initial denaturation of 3 min at 98°C; 30 cycles of 30 s at 98°C, 1 min at 67°C, and
3 min at 72°C; and a final extension step of 5 min at 72°C. The PCR product was
purified and subcloned into pUC18 as a HindIII-XbaI fragment and then rescued
as an NheI-XbaI fragment for subcloning into the XbaI site of pOLV in the right
orientation and downstream of ermEp. This construct (pOLE) contained all
putative dTDP-L-oleandrose-biosynthetic genes.
Biotransformation of erythronolide B. Spores of S. albus IAGS1 and S. albus
IAGS2 were inoculated into TSB containing 2.5 mg of thiostrepton/ml. After
incubation for 24 h at 30°C and 250 rpm, the mycelium obtained was used to
inoculate plates with 25 ml of solid R5 medium modified as previously described
(14), supplemented with 25 mg of thiostrepton/ml and 100 mg of erythronolide
B/ml. Four plates were inoculated with each strain so as to obtain confluent
growth. After 6 days of incubation at 28°C, solid cultures of each strain were
extracted twice with 50 ml of ethyl acetate, and the resulting extracts were
evaporated under a vacuum and finally redissolved in 500 ml of methanol.
Chromatographic techniques. Thin-layer chromatography was performed on
precoated silica gel 60 F254 plates using dichloromethane-methanol (90:10,
vol/vol) as a solvent. Erythromycin-related compounds were stained by spraying
the plates with p-anisaldehyde–sulfuric acid–ethanol (1:1:9, vol/vol/vol), followed
by heating at 100°C for about 30 s. High-performance liquid chromatographic
(HPLC) analysis was performed using a Symmetry C18 column (Waters) with
acetonitrile and water as solvents. Samples were eluted with a gradient from 10
to 50% acetonitrile in 20 min, followed by 10 min under isocratic conditions in
50% acetonitrile. The flow rate was 1 ml/min, and detection was done with a
photodiode array detector (Waters), monitoring peaks at 210 nm. New peaks
with absorption spectra identical to that of erythronolide B were collected and
analyzed by thin-layer chromatography. The new products were purified with
several injections using the same column and solvents described for analysis, but
mobile-phase conditions were optimized in each case. The new product made by
S. albus NAG2(pOLV) was isolated with 30% acetonitrile in water under iso-
cratic conditions. For the derivative corresponding to S. albus NAG2(pOLE), a
linear gradient from 25 to 50% acetonitrile in 30 min was used.
Metabolite identification. HPLC analyses were performed on a GILSON
liquid chromatography system equipped with a variable wavelength detector at
215 nm and a Kromasil C18 5-mm stainless steel column (inside diameter, 250 by
4.6 mm) fitted with a Kromasil C18 5-mm precolumn (inside diameter, 50 by 4.6
mm). The mobile phase was acetonitrile–methanol–0.065 M ammonium acetate
(pH 6.7) (35:15:50, vol/vol/vol). The flow rate of the mobile phase was 1.0 ml/min,
and the column was operated at 30°C. HPLC coupled to mass spectrometry was
carried out on a chromatography system (Waters) equipped with a FINNIGAN
TSQ 7000 mass spectrometer (full scan range from 0 to 750 average mass units).
Nucleotide sequence accession number. The 9.8-kb DNA region containing
oleW, oleV, oleL, oleS, oleE, oleU, oleNI, and oleT has been submitted to Gen-
Bank under accession no. AF055579.
RESULTS
Cloning and sequencing of a chromosomal region of S. an-
tibioticus encoding sugar-biosynthetic genes. A cosmid library
of chromosomal DNA from S. antibioticus (44) was screened
by in situ colony hybridization using as probes the strD, strE,
and strM genes of Streptomyces griseus, which encode several
enzymes catalyzing early stages in the biosynthesis of the sugar
moieties in the streptomycin pathway. These genes have been
shown to be useful probes for the isolation of gene clusters
involved in the biosynthesis of the 6-deoxysugar moieties of
different antibiotics (51). Using these genes as probes, we iso-
lated two overlapping clones (cosAB61 and cosAB63) which
simultaneously hybridized against the three probes. Using
Southern hybridization it was found that the hybridization
bands corresponded to three adjacent BamHI fragments of 2.2
(hybridization against the strM probe), 1.1 (strD and strE
probes), and 4 (strE probe) kb (Fig. 1B). These two cosmid
clones overlapped with several other clones previously isolated
in our laboratory that contain the oleandomycin polyketide
synthase genes. A 9.8-kb DNA region including the three hy-
bridizing BamHI fragments and surrounding DNA was se-
quenced. The sequence was analyzed for open reading frames
(ORFs) using the CODONPREFERENCE program (9).
Eight ORFs were found, of which two were transcribed in one
direction (oleW and oleV) and the other six (oleL, oleS, oleE,
oleU, oleNI, and oleT) were transcribed divergently from the
first two (Fig. 1B). Five of the genes (oleL, oleS, oleE, oleU, and
oleNI) showed some overlapping sequences between the stop
codon of one gene and the start codon of the next one. This is
usually considered an indication of translational coupling (33).
Deduced functions of the gene products. (i) oleW. The oleW
gene is located at one end of the cluster upstream of the PKS
genes. It appears to start at an ATG codon 19 nucleotides
downstream from the stop codon of oleV, with a putative ri-
bosomal-binding site 5 nucleotides upstream of the initiation
codon (GAAGGGA). The gene spans 987 nucleotides, and
downstream of its TGA codon there is a noncoding region with
a length of approximately 600 nucleotides, containing DNA
sequences that could form secondary structures that could act
as transcriptional terminators. The deduced product of oleW is
a protein of 327 amino acid residues (Mr, 35,834) closely re-
lated to LanT from the landomycin gene cluster of Streptomy-
ces cyanogenus (50.8% identity) (59), Gra-orf26 from the
granaticin biosynthetic gene cluster of Streptomyces violaceoru-
ber (49.1% identity) (22), an oxidoreductase from the rifamy-
cin pathway of Amycolatopsis mediterranei (48.9% identity) (2),
and RdmF from the rhodomycin biosynthetic pathway of Strep-
tomyces purpurascens (48.9% identity) (32). It has recently
been shown that Gra-orf26 (together with Gra-orf27) partici-
pates in the 2-deoxygenation of the oleandrose molecule of
granaticin (13). Based on the similarity between OleW and
Gra-orf26 (Fig. 2), OleW could be a 3-ketoreductase function-
ing in combination with OleV to achieve the C-2 deoxygen-
ation step of the oleandrose moiety of oleandomycin.
(ii) oleV. The oleV gene is 1,425 nucleotides long and starts
with an ATG codon located 335 nucleotides upstream of the
initiation codon of oleL and diverging from it. A peculiarity of
the oleV gene is the presence in its sequence of a TTA codon.
The TTA codon has been proposed to be involved in the
regulation of differentiation and secondary metabolism in
Streptomyces (25). The deduced protein product of oleV (a
protein of 474 amino acid residues and an estimated Mr of
53,149) shows strong sequence similarity to DnmT from the
daunosamine pathway in Streptomyces peucetius (52.8% iden-
tity) (49), Gra-orf27 from the granaticin pathway in S. viola-
ceoruber (50.7% identity) (22), SnoH from the nogalamycin
pathway in Streptomyces nogalater (51.5% identity) (64), ORF3
from Streptomyces sp. strain C5 (48.2% identity) (11), and
EryBVI from the erythromycin pathway in S. erythraea (51.1%
identity) (16, 53). Based on these similarities and on the pro-
posed function for the above-mentioned Gra-orf27 protein
(13), a function as a 2,3-dehydratase can be assigned to the
OleV protein in L-oleandrose biosynthesis in S. antibioticus.
(iii) oleL. The oleL gene starts with an ATG codon and ends
in a TGA stop codon. This gene contains in its sequence three
TTA codons, two of which, interestingly, are located close to
the 59 end of the gene (3rd and 11th codon positions, respec-
tively), which is in agreement with a potential role in the
regulation of secondary metabolism. The oleL gene would
code for a polypeptide of 204 amino acids and an estimated Mr
of 22,248. Comparison of the deduced product of this gene
with proteins in databases showed clear similarities with vari-
ous dTDP-4-keto-6-deoxyglucose 3,5-epimerases involved in
6-deoxysugar biosynthesis in the streptomycin pathway by
Streptomyces glaucescens (50% identity; PIR accession no.
S44236), the StrM epimerase from S. griseus, which is also
involved in streptomycin biosynthesis (50% identity) (40), the
EryBVII protein from the erythromycin pathway from S. eryth-
raea (42.4% identity) (16, 53), and the DnmU protein from the
daunorubicin pathway in S. peucetius (42.8% identity) (37).
OleL also resembles different RfbC proteins involved in lipo-
polysaccharide biosynthesis in Mycobacterium tuberculosis (7)













and Shigella flexneri (30). On the basis of the above-mentioned
similarities, the OleL protein would be responsible for the
epimerization occurring at carbons 3 and 5 of the correspond-
ing dTDP intermediate in the biosynthesis of L-oleandrose.
Confirmation for this role was obtained by complementing a
non-erythromycin-producing mutant from S. erythraea (strain
BVII98) defective in 3,5-epimerase activity. Expression of the
oleL gene in this mutant under the control of ermEp restored
erythromycin production as detected by a bioassay against Ba-
cillus subtilis and thin-layer chromatography using erythromy-
cin A as a standard.
(iv) oleS. The oleS gene starts at a GTG codon and would
end in a TGA codon. It would code for a polypeptide of 356
amino acids and an Mr of 38,109. Its deduced product showed
clear similarities with dTDP-D-glucose synthases from strepto-
mycetes involved in the biosynthesis of different antibiotics.
The highest scores were with MtmD from the mithramycin
pathway in Streptomyces argillaceus (70.2% identity) (28), StrD
from the streptomycin pathway in S. griseus (68.2% identity)
(40), and DnmL from the daunorubicin pathway in S. peucetius
(58.1% identity) (18). All of these enzymes show a well-con-
served motif close to the N terminus (LAGGSGTRLRP in
OleS) (31). These enzymes are presumed to be involved in the
activation of glucose-1-phosphate into dTDP-D-glucose as the
earliest step in 6-deoxysugar biosynthesis. In the case of the
MtmD synthase (28), such activity has been demonstrated by
an in vitro enzymatic assay.
(v) oleE. The translational starting codon (ATG) of the oleE
gene also overlaps the stop codon of the previous gene (oleS).
It would code for a polypeptide of 335 amino acids with an
estimated Mr of 36,664. Its deduced product showed high sim-
ilarity with several enzymes that have been proposed to par-
ticipate in 4,6-dehydration during 6-deoxysugar biosynthesis:
MtmE from the mithramycin pathway in S. argillaceus (70.2%
identity) (28), StrE from the streptomycin pathway in S. griseus
(64.7% identity) (40), Gdh from S. erythraea, a dehydratase
which has been shown not to be involved in erythromycin
biosynthesis (64.2% identity) (26), and TylA2 from the tylosin
pathway in Streptomyces fradiae (63% identity) (31). An inter-
esting feature of all these proteins is the presence of a con-
served sequence close to the N terminus which contains a bab
fold with an NAD1 binding motif, GXGXXG (50, 60). This
FIG. 2. Alignment of OleW and related proteins. LanT, landomycin biosynthetic pathway of S. cyanogenus (59); Oxidored, oxidoreductase from the rifamycin
pathway of A. mediterranei (2); GraORF26, granaticin biosynthetic pathway of S. violaceoruber (22); RdmF, rhodomycin biosynthetic pathway of S. purpurascens (32).
Amino acids that are identical in at least three of the five proteins compared are shown on a solid background, and conservative substituted amino acids are shown
on a shaded background.













4,6-dehydration activity has been demonstrated in vitro for
TylA2 (32) and MtmE (29). Therefore, OleE might act as a
dTDP-glucose 4,6-dehydratase involved in early steps of the
biosynthesis of D-desosamine and L-oleandrose.
(vi) oleU. oleU is immediately downstream of oleE and also
shows an apparent translational coupling with it. The oleU
gene would code for a polypeptide of 295 amino acids and an
estimated Mr of 32,098. The OleU deduced product displays
similarity to a large family of sugar reductases involved in
antibiotic biosynthesis: StrL from the streptomycin pathway in
S. griseus (57.4% identity) (40), DnmV from the daunorubicin
pathway in S. peucetius (27.8% identity) (37), and EryBIV from
the erythromycin pathway in S. erythraea (24.8% identity) (16,
53). It also resembles the well-characterized UDP-galactose
4-epimerase encoded by the galE gene of E. coli (3). All the
members of this family, including OleU, contain two con-
served motifs: one close to the N terminus which is charac-
teristic of a nucleotide-binding site (60) and a second motif
(YGRFKRDGE in OleU) in which the tyrosine and lysine
residues have been found to be involved in cofactor binding
(3). On the basis of similarities with known 4-ketoreductases
(DnmV and EryBIV), it is proposed that OleU encodes a
4-ketoreductase involved in L-oleandrose biosynthesis.
(vii) oleNI. The oleNI gene starts at an ATG codon and ends
in a TAG codon. It would code for a polypeptide of 393 amino
acids and an Mr of 42,673. The OleNI protein showed similar-
ity with several aminotransferases involved in the biosynthesis
of 6-deoxysugars in various antibiotic-biosynthetic pathways:
EryCIV from the erythromycin pathway (65% identity) (16,
53), TylB from the tylosin pathway (32.1% identity) (31), DnrJ
from the daunorubicin pathway (29.8% identity) (52), and
LmbS from the lincomycin pathway (32.6% identity) (38). All
of these proteins are similar to the well-characterized AscC
dehydratase from the ascarylose pathway in Yersinia pseudotu-
berculosis (55). Based on the similarity of OleNI with EryCIV,
a role is proposed for this protein in the 3,4-dehydration step
occurring during D-desosamine biosynthesis. OleN2 (43), ho-
mologous to EryCI, would be responsible for the C-3 transam-
ination reaction.
(viii) oleT. One hundred ten base pairs downstream of oleNI
there is a gene, oleT, that would code for a polypeptide of 485
amino acids with an estimated Mr of 53,774. Comparison with
databases showed similarity with two proteins involved in mac-
rolide biosynthesis: DesII from the methymycin and pikromy-
cin pathways (57.2% identity) (62) and EryCV from the eryth-
romycin pathway of S. erythraea (56.7% identity) (16, 53). Both
enzymes have been proposed to be involved in D-desosamine
biosynthesis in these pathways, probably by acting as 3,4-re-
ductases. By analogy, OleT could be responsible for the 3,4-
reduction step in D-desosamine biosynthesis in S. antibioticus.
Construction of an S. albus strain expressing the olean-
drosyl glycosyltransferase. In the oleandomycin gene cluster,
three genes encoding glycosyltransferases have been described:
oleI (43) and oleG1 and oleG2 (35). The first of these codes for
a macrolide-inactivating glycosyltransferase responsible for the
formation of an inactive glycosylated derivative during olean-
domycin biosynthesis (43). The other two glycosyltransferases
are involved in the transfer of D-desosamine and L-oleandrose
to the oleandolide, as was demonstrated by gene disruption
(35). Recently, it has been shown that oleG1 complements an
S. erythraea mutant lacking eryCIII and that oleG2, when trans-
formed into a mutant lacking eryBV, produces a new com-
pound that contains a rhamnosyl residue attached to the C-3
position of the erythronolide B (12). Therefore, it has been
proposed that OleG1 and OleG2 act as the D-desosaminyl- and
L-oleandrosyl-glycosyltransferases, respectively (12). In order
to test the capability of the putative oleandrose-biosynthetic
genes to make dTDP-L-oleandrose, and the substrate flexibility
of the OleG2 glycosyltransferase, we generated an appropriate
S. albus strain expressing the OleG2 oleandrosyl glycosyltrans-
ferase. The oleG2 gene was subcloned under the control of the
ermE* promoter in an integrative bifunctional (Streptomyces-E.
coli) plasmid vector, pKCE. In the opposite direction to the
oleG2 gene, we also subcloned the erythromycin resistance
gene (ermE) and its promoter to provide the new strain with
the capability of surviving if new erythromycin-like compounds
were synthesized. This strain (NAG2) was now used as a host
for transformation with plasmid constructs capable of synthe-
sizing two different dTDP-activated sugars: dTDP-L-olivose
(pOLV) and dTDP-L-oleandrose (pOLE).
Construction of plasmids synthesizing dTDP-activated sug-
ars. To test if the genes assigned were sufficient for dTDP-L-
oleandrose biosynthesis, we constructed two different plas-
mids. The first (pOLE) possesses all the genes that are
predicted to be necessary for the biosynthesis of the activated
L-oleandrose: genes encoding glucose synthase (oleS), 4,6-de-
hydratase (oleE), 3,5-epimerase (oleL), 2,3-dehydratase (oleV),
3-reductase (oleW), 3-O-methyltransferase (oleY), and 4-ke-
toreductase (oleU). All of these genes were under the control
of their own promoters, except oleY, which was dependent on
ermEp. In the second construct (pOLV), the oleY gene was
absent, and therefore this construct would produce dTDP-3-
demethyl-L-oleandrose (i.e., dTDP-2-deoxy-L-rhamnose, also
designated dTDP-L-olivose). Both plasmids were indepen-
dently transformed into S. albus strain NAG2, which harbors
the oleG2 gene (oleandrosyl glycosyltransferase) integrated
into the chromosome (see the preceding section). The choice
of S. albus as a host was based on (i) its ability to grow in a
well-dispersed way, (ii) the possibility of having good transfor-
mation frequencies, and (iii) the fact that it is not known to
produce any glycosylated secondary metabolite.
Generation of 3-L-olivosyl-erythronolide B and 3-L-olean-
drosyl-erythronolide B. Bioconversion experiments were then
carried out to demonstrate that pOLV and pOLE code for the
biosynthesis of dTDP-L-olivose and dTDP-L-oleandrose, re-
spectively. S. albus NAG2 containing either pOLV or pOLE
(strain IAGS1 or IAGS2, respectively) was incubated in the
presence of the erythromycin aglycone (erythronolide B), and
after incubation, the presence of glycosylated erythronolide B
derivatives was analyzed by thin-layer chromatography and
HPLC. In both experiments it was found that approximately
50% of the erythronolide B added was converted into new
compounds when biotransformation was carried out on a solid
medium. In liquid cultures, the efficiencies obtained were
lower. Control experiments were made using as a biotransfor-
mation host S. albus NAG2 containing the plasmid vector
pIAGO, resulting in no modification of the erythronolide B
precursor. In strain IAGS1 (harboring pOLV), the new com-
pound ran slower than erythronolide B on thin-layer chroma-
tography plates, while in strain IAGS2 (harboring pOLE), the
new compound ran faster (Fig. 3A and 4A). New peaks were
also detected by HPLC analysis (data not shown). The material
present in these new HPLC peaks was collected and found to
correspond exactly to the new thin-layer chromatography
spots. In order to investigate further the structure of the com-
pounds produced by the new recombinant strains, purified
extracts made from culture supernatants were analyzed by
HPLC coupled to mass spectrometry. In the case of strain
IAGS1, one metabolite eluting at 30 min, named M1, gave
parent peaks at m/z 555 and 550 for sodium and ammonium
ions, respectively, as well as a peak at m/z 515 for the dehy-
drated H1 ion form (Fig. 3B; Table 2). A fragmentation peak













present at m/z 385 can be interpreted as dehydrated erythro-
nolide B (H1 ion). The difference of 130 compared to the 515
parent peak can be traced to the neutral sugar residue, which
is consistent with olivose. The M1 compound can therefore be
interpreted as 3-L-olivosyl-erythronolide B (Fig. 3C). In the
case of strain IAGS2, one metabolite named M2 eluting at
26:36 min gave parent peaks at m/z 569 and 564 for sodium and
ammonium ions, respectively, as well as a peak at m/z 529 for
the dehydrated H1 ion form (Fig. 4B; Table 2). A fragmenta-
tion peak present at m/z 385 which can be interpreted as
dehydrated erythronolide B (H1 ion form) indicates a differ-
ence of 144 (compared to peak 529), corresponding to the loss
of the neutral sugar residue. These results are consistent with
the interpretation of M2 as being 3-L-oleandrosyl-erythronol-
ide B (Fig. 4C).
DISCUSSION
A number of antibiotics and antitumor agents possess de-
oxysugars attached to their aglycones; in many cases, these
deoxysugars are essential for their biological activity. They
belong to the family of 6-deoxyhexoses and are commonly
synthesized through dTDP-activated intermediates (27, 39,
56). However, the biochemical pathways involved in 6-deoxy-
hexose biosynthesis have not been characterized in most cases.
Several authors have reported the cloning of different genes
involved in the biosynthesis of 6-deoxyhexoses in antibiotic and
antitumor pathways: streptomycin (40), erythromycin (10, 16,
46, 53), tylosin (15, 19, 31), daunosamine (36, 37), lincomycin
(38), mithramycin (28), methymycin-pikromycin (62), and
granaticin (4, 22). Macrolide antibiotics contain mono- or di-
saccharides attached to the macrolactone rings which are im-
portant for activity. Oleandomycin shares some structural fea-
tures with erythromycin. They both belong to the 14-unit
macrolides and contain D-desosamine attached to the aglycone
via the hydroxyl group at C-5. However, they differ in the other
sugar at C-3, L-mycarose in erythromycin and L-oleandrose in
oleandomycin. In previous papers we have reported the isola-
tion of several genes of the oleandomycin gene cluster in S.
antibioticus (34, 35, 43, 45, 54). The eight additional genes we
report here (oleW, oleV, oleL, oleS, oleE, oleU, oleNI, and
oleT), together with other six genes previously reported (oleN2,
oleP1, oleG1, oleG2, oleM1, and oleY) (35, 43), constitute the
FIG. 3. Analysis of the products of the biotransformation of erythronolide B
by strain IAGS1. (A) Thin-layer chromatography analysis of the reaction. EB,
erythronolide B; St, standard; 1 and 2, incubation in the presence and absence
of EB, respectively. (B) Mass spectrometry analysis of compound M1. (C) Struc-
ture of 3-L-olivosyl-erythronolide B.
TABLE 2. Mass spectrometry data for metabolites produced by










1 385 11 11
[EB–2H2O]H
1 367 11 11
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set of genes encoding the enzymatic functions required for the
biosynthesis and transfer of the two 6-deoxyhexoses in the
oleandomycin molecule. The involvement of the isolated gene
cluster in oleandomycin biosynthesis came from the following
evidence: (i) the high similarities of the gene products identi-
fied with homologous proteins in the erythromycin cluster, (ii)
the presence in the cloned cluster of resistance genes specifi-
cally conferring resistance to oleandomycin and not to other
macrolides (34, 43, 44), and (iii) the complete abolishment of
oleandomycin biosynthesis by the inactivation of one of the
genes of the cluster, oleG1 (35).
Of the eight genes described in this paper, four would code
for L-oleandrose-specific biosynthetic enzymes (oleW, oleV,
oleL, and oleU) and two would code for D-desosamine-specific
biosynthetic enzymes (oleNI and oleT). The other two genes
(oleS and oleE) would code for two enzymes catalyzing early
steps common to the biosynthesis of both deoxysugars: a glu-
cose-1-phosphate: TTP thymidylyl transferase (OleS) cata-
lyzing the activation of glucose-1-phosphate into dTDP-glu-
cose and a dTDP-glucose 4,6-dehydratase (OleE) responsible
for the conversion of dTDP-glucose into dTDP-4-keto-6-de-
oxyglucose. These two enzymes are well conserved in most of
the sugar-biosynthetic pathways so far characterized, with the
exception of the erythromycin pathway, where no gene encod-
ing a synthase or a dehydratase has been identified within the
cluster. The dTDP-4-keto-6-deoxyglucose intermediate gener-
ated by the action of these two enzymes is a common interme-
diate in the biosynthesis of both dTDP-D-desosamine and
dTDP-L-oleandrose.
D-Desosamine is an aminosugar which is present in many
macrolide antibiotics (erythromycin, oleandomycin, methymy-
cin-pikromycin, etc.). Desosamine-biosynthetic genes from the
erythromycin producer (eryC genes) have been independently
characterized by different laboratories (16, 46, 53). We have
found five genes (oleNI, oleT, oleN2, oleP1, and oleM1) in the
oleandomycin cluster showing high similarities to eryC genes;
this indicates that probably this aminosugar is synthesized in
both producer strains through similar biosynthetic pathways
(Fig. 5).
L-Oleandrose is a neutral sugar not frequently found in bio-
active compounds. It is present as a monosaccharide in olean-
domycin and as a disaccharide in the antihelmintic avermec-
tins. Several enzymatic steps are required for the conversion of
dTDP-4-keto-6-deoxyglucose into dTDP-L-oleandrose: C-2 de-
oxygenation, epimerization at C-3 and C-5, C-4 ketoreduction,
and C-3 O-methylation. L-Oleandrose and L-mycarose are 2,6-
deoxyhexoses, and therefore their biosynthesis will require en-
zymes catalyzing C-2 deoxygenation. In the erythromycin path-
way in S. erythraea, it has been proposed that two enzyme
activities are involved in C-2 deoxygenation during L-mycarose
biosynthesis: the EryBVI (2,3-dehydratase) and EryBII (2,3-
reductase) proteins (16, 53). The oleandomycin cluster also
contains a gene encoding an EryBVI-like protein (oleV). How-
ever, we did not find an eryBII-like gene either within the
oleandomycin cluster or in the chromosome. Our attempts to
identify such a gene in the chromosome of S. antibioticus were
unsuccessful, both by use of the eryBII gene from S. erythraea
as a probe and by PCR amplification using oligoprimers de-
rived from the eryBII sequence. Interestingly, an eryBII-like
gene for L-oleandrose biosynthesis has been described in the
avermectin cluster of Streptomyces avermitilis (cited in refer-
ence 29). However, it has recently been shown by in vitro
studies that 2-deoxygenation during 6-deoxyhexose biosynthe-
sis requires the participation of two enzymes (Orf10 and
Orf11) in S. antibioticus Tu¨99 and two enzymes (Gra-Orf27
FIG. 4. Analysis of the products of the biotransformation of erythronolide B
by strain IAGS2. (A) Thin-layer chromatography analysis of the reaction. EB,
erythronolide B; St, standard; 1 and 2, incubation in the presence and absence
of EB, respectively. (B) Mass spectrometry analysis of compound M2. (C) Struc-
ture of 3-L-oleandrosyl-erythronolide B.













and Gra-Orf26) in S. violaceoruber Tu¨22 (13). The OleV and
OleW proteins show high similarity to Gra-Orf27 (50.7% iden-
tical amino acids) and Gra-Orf26 (49.1% identical amino ac-
ids). Consequently, 2-deoxygenation during L-oleandrose bio-
synthesis in S. antibioticus ATCC 11891 could be mediated by
OleV and OleW without the involvement of an EryBII-like
protein.
Erythronolide B was biotransformed by S. albus strains
IAGS2 (containing oleG2 and pOLE) into 3-L-oleandrosyl
erythronolide B. This demonstrates that the set of genes
formed by oleS, oleE, oleV, oleW, oleL, oleU, and oleY is able to
synthesize L-oleandrose. Interestingly, another strain (IAGS1)
containing the same set of genes, but lacking the 3-O-methyl-
transferase (oleY gene), transferred L-olivose to erythronolide
B, generating 3-L-olivosyl-erythronolide B. This indicates that
the oleandrose genes are also able to synthesize dTDP-L-oli-
vose, an unmethylated form of dTDP-L-oleandrose, suggesting
that dTDP-L-olivose could be an intermediate in dTDP-L-ole-
androse biosynthesis (Fig. 5). Several eryB and eryC mutants
have been found to incorporate some intermediates in D-des-
osamine and L-mycarose biosynthesis into the erythromycin
aglycone, but as minor compounds with low efficiency (17, 46).
Interestingly, the formation of the two glycosylated derivatives
of erythronolide B reported in this work was quite efficient,
with a bioconversion rate of approximately 40% of the origi-
nally added precursor and no significant difference between
the transfer of L-oleandrose and that of L-olivose. These mac-
rolide derivatives are the first two hybrid glycosylated macro-
lides generated by biotransformation of a macrolide aglycone
in a non-macrolide-producing host in which a 6-deoxyhexose-
biosynthetic gene cluster has been expressed. Generation of
novel glycosylated derivatives of medically important bioactive
compounds by genetic engineering requires both the construc-
tion of a plasmid synthesizing activated sugars and the use of
glycosyltransferases that are flexible in some way. The two
constructs shown in this work (pOLV and pOLE) are the first
two plasmids reported capable of synthesizing dTDP-activated
sugars, and so they have the potential to be used for modifying
different aglycones. This will require the use of “flexible” gly-
cosyltransferases, and in this context, a few examples of glyco-
syltransferase substrate flexibility have been reported (8, 46,
61). The S. antibioticus OleG2 glycosyltransferase has been
shown to transfer L-oleandrose and L-olivose (this work) and
also L-rhamnose (12). This “substrate flexibility” of the OleG2
glycosyltransferase opens up the possibility of using this sugar
transfer enzyme as a genetic tool for further studies leading to
the generation of novel glycosylated macrolides.
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